Cardio Diagnostics enters nationwide telehealth agreement with Navierre

Cardio Diagnostics Holdings announces a strategic partnership with Navierre. This collaboration aims to significantly expand access to Cardio Diagnostics’ industry-leading, AI-enabled precision cardiovascular diagnostic tests. “We are thrilled to partner with Navierre to make our industry-leading cardiovascular clinical tests more widely available to patients and clinicians nationwide,” said Meesha Dogan, Ph.D., CEO and Co-Founder of Cardio Diagnostics. “Navierre’s innovative platform aligns with our mission to transform cardiovascular care through AI-driven precision diagnostics and personalized prevention strategies.”